{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:39:54Z","timestamp":1773009594009,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1212\/01.con.0000418646.70149.71","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T18:56:31Z","timestamp":1381517791000},"page":"835-852","source":"Crossref","is-referenced-by-count":8,"title":["Migraine in Women"],"prefix":"10.1212","volume":"18","author":[{"given":"Jan Lewis","family":"Brandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Lipton RB Stewart WF Diamond S et al.. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41 (7): 646\u2013657.","DOI":"10.1046\/j.1526-4610.2001.041007646.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Granella F Sances G Allais G et al.. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 2004; 24 (9): 707\u2013716.","DOI":"10.1111\/j.1468-2982.2004.00741.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Hershey A Horn P Kabbouche M et al.. Genomic expression patterns in menstrual-related migraine in adolescents. Headache 2012; 52 (1): 68\u201379.","DOI":"10.1111\/j.1526-4610.2011.02049.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Nett R Landy S Shackelford S et al.. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003; 102 (4): 835\u2013842.","DOI":"10.1097\/00006250-200310000-00027"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Mannix LK Loder E Nett R et al.. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective randomized placebo-controlled double-blind studies. Cephalalgia 2007; 27 (5): 414\u2013421.","DOI":"10.1111\/j.1468-2982.2007.01313.x"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Newman L Mannix LK Landy S et al.. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized double-blind placebo-controlled study. Headache 2001; 41 (3): 248\u2013256.","DOI":"10.1046\/j.1526-4610.2001.111006248.x"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Brandes JL Poole AC Kallela M et al.. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 2009; 29 (11): 1133\u20131148.","DOI":"10.1111\/j.1468-2982.2009.01840.x"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Sances G Martignoni E Fioroni L et al.. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990; 30 (11): 705\u2013709.","DOI":"10.1111\/j.1526-4610.1990.hed3011705.x"},{"key":"e_1_3_1_21_2","unstructured":"Boyle CA. Management of menstrual migraine. Neurology 1999; 53 (4 suppl 1): S14\u2013S18."},{"key":"e_1_3_1_22_2","unstructured":"US Department of Health and Human Services Office of Women\u2019s Health. Preconception health. http:\/\/www.womenshealth.gov\/pregnancy\/before-you-get-pregnant\/preconception-health.cfm. Updated September 27 2010. Accessed June 18 2012."},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"De Lignieres B Vincens M Mauvais-Jarvis P et al.. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986; 293 (6561): 1540.","DOI":"10.1136\/bmj.293.6561.1540"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Dennerstein L Morse C Burrows G Oats J et al.. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988; 2 (2): 113\u2013120.","DOI":"10.3109\/09513598809023619"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Smits MG van der Meer YG Pfeil JP et al.. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1993; 34 (2): 103\u2013106.","DOI":"10.1111\/j.1526-4610.1994.hed3402103.x"},{"key":"e_1_3_1_26_2","unstructured":"Pradalier A Vincent D Beaulieu PH et al.. Correlation between estradiol plasma level and therapeutic effect on menstrual migraine. Proc 10th Migraine Trust Symp 1994; 129\u2013132."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Loder EW Buse DC Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 2005; 193 (3 pt 1): 636\u2013649.","DOI":"10.1016\/j.ajog.2004.12.089"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"ACOG Committee on Practice Bulletins: Gynecology. ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107 (6): 1453\u20131472.","DOI":"10.1097\/00006250-200606000-00055"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Allais G Gabellari IC De Lorenzo C et al.. Oral contraceptives in migraine therapy. Neurol Sci 2011; 32 (suppl 1): S135\u2013S139.","DOI":"10.1007\/s10072-011-0538-z"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Nappi EW Sances G Allais G et al.. Effects of an estrogen-free desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception 2011; 83 (3): 223\u2013228.","DOI":"10.1016\/j.contraception.2010.07.024"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Sances G Granella F Nappi R et al.. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23 (3): 197\u2013205.","DOI":"10.1046\/j.1468-2982.2003.00480.x"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Kvisvik EV Stovner LJ Helde G et al.. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 2011; 12 (4): 443\u2013451.","DOI":"10.1007\/s10194-011-0329-1"},{"key":"e_1_3_1_34_2","unstructured":"University of Washington. FDA pregnancy category. depts.washington.edu\/druginfo\/Formulary\/Pregnancy.pdf. Accessed June 14 2012."},{"key":"e_1_3_1_35_2","unstructured":"The sumatriptan\/naratriptan\/Treximet pregnancy registry interim report: 1 January 1996 through 30 April 2011. pregnancyregistry.gsk.com\/documents\/SumNarTrex_InterimReport_2011.pdf. Issued August 2011. Accessed April 6 2012."},{"key":"e_1_3_1_37_2","unstructured":"US Food and Drug Administration. FDA drug safety communication: risk of oral clefts in children born to mothers taking Topamax (topiramate). www.fda.gov\/Drugs\/DrugSafety\/ucm245085.htm. Updated March 7 2011. Accessed May 4 2012."},{"key":"e_1_3_1_39_2","unstructured":"Briggs GG Freeman RK Yaffe SJ. Drugs in pregnancy and lactation 6th ed. Philadelphia PA: Lippincott Williams & Wilkins 2002."},{"key":"e_1_3_1_40_2","unstructured":"World Health Organization Scientific Group. Report of WHO Scientific Group: research on the menopause in the 1990\u2019s. Geneva Switzerland: World Health Organization 1996."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Neri I Granella F Nappi R et al.. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993; 17 (1): 31\u201337.","DOI":"10.1016\/0378-5122(93)90121-W"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Rossouw JE Anderson GL Prentice RL et al.. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002; 288 (3): 321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Facchinetti F Nappi RE Tirelli A et al.. Hormone supplementation differently affects migraine in postmenopausal women. Headache 2002; 42 (9): 924\u2013929.","DOI":"10.1046\/j.1526-4610.2002.02215.x"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","unstructured":"Martin V Wernke S Mandell K et al.. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003; 43 (4): 309\u2013321.","DOI":"10.1046\/j.1526-4610.2003.03065.x"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","unstructured":"Spector JT Kahn SR Jones MR et al.. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010; 123 (7): 612\u2013624.","DOI":"10.1016\/j.amjmed.2009.12.021"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","unstructured":"Bousser MG. International Headache Society (IHS) Task Force on oral contraceptives (OCs) and hormone replacement therapy (HRT) used in migraine sufferers. Cephalalgia 2000; 20 (3): 147; discussion 145\u2013146.","DOI":"10.1046\/j.1468-2982.2000.00050.x"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","unstructured":"Sherwin BB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 2007; 19 (2): 77\u201381.","DOI":"10.1111\/j.1365-2826.2006.01508.x"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","unstructured":"Zhang Q-G Raz L Wang R et al.. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha\u2013mediated inhibition of NADPH oxidase activation. J Neurosci 2009; 29 (44): 13823\u201313836.","DOI":"10.1523\/JNEUROSCI.3574-09.2009"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","unstructured":"Breslau N Lipton RB Stewart WF et al.. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60 (8): 1308\u20131312.","DOI":"10.1212\/01.WNL.0000058907.41080.54"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","unstructured":"Tietjen GE Brandes JL Digre KB et al.. History of childhood maltreatment is associated with comorbid depression in women with migraine. Neurology 2007; 69 (10): 959\u2013968.","DOI":"10.1212\/01.wnl.0000271383.60376.67"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/01.CON.0000418646.70149.71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:06:57Z","timestamp":1752156417000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/01.CON.0000418646.70149.71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1212\/01.CON.0000418646.70149.71"],"URL":"https:\/\/doi.org\/10.1212\/01.con.0000418646.70149.71","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}